References
- Arrang J M, Garbarg M, Schwartz J C. Autoinhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 1983; 302: 832–7
- Timmerman H. Histamine H3 ligands: just pharniacological tools or potential therapeutic agents?. J Med Chein 1990; 33: 4–11
- Timmerman H. Histamine agonists and antagonists. Acta Otolaryngol (Stockh) 1991; Suppl 479: 5–11
- Timmerman H. Histamine receptors in the central nervous system. Pharm Weekbl (Sci) 1989; 11: 146–50
- Arrang J M, Garbarg M, Schwartz J C. Autoinhibition of histamine synthesis mediated by presynaptic H3-receptors. Neuroscience 1987; 23: 149–57
- Schwartz J C, Arrang J M, Garbarg M, Pollarol H. A third histamine receptor type: characterisation, localisation and functions of the H3-receptor. Agents Actions 1990; 30: 13–23
- Steinbusch H WM. Distribution of histaminergic neurons and fibers in rat brain. Acta Otolaryngol (Stockh) 1991; Suppl 479: 12–23
- Arrang J M, Devaux B, Chodkiewicz J P, Schwartz J C. H3-receptors control histamine release in human brain. J Neurochem 1988; 51: 105–8
- Wada H, Inagaki N, Yamatodani A. Is the histaminergic neuron system a regulatory centre for whole-brain activity?. TINS 1991; 14: 415–8
- Garbarg M, Trung Tuong M D, Gros C, Schwartz J C. Effects of histamine H,-receptor ligands on various biochemical indices of histaminergic neuron activity in rat brain. Eur J Pharmacol 1989; 164: 1–11
- Arrang J M, Garbarg M, Lancelot J C, et al. Highly potent and selective ligands for histamine H3–receptors. Nature 1987; 327: 117–23
- Lin J S, Sakai K, Vanni-Mercier G, et al. Involvement of histaminergic neurons in arousal mechanisms demonstrated with H3 -receptor ligands in the cat. Brain Res 1990; 523: 325–30
- Fisher A JEM. Histamine in the treatment of vertigo. Acta Otolaryngol (Stockh) 1991; Suppl 479: 24–28
- Arrang J M, Garbarg M, Thanh Quach T, Dam Trung Tuong M, Yeramian E, Schwartz J C. Actions of be-tahistine at histamine receptors in the brain. Eur J Pharm 1985; 111: 73–84
- Anderson W D, Kubicek W G. Effects of betahis-tine hydrochloride, nicotinic acid and histamine on basilar blood flow in anesthetized dogs. Stroke 1971; 2: 409
- Suga F, Snow J B. Cochlear blood flow in response to vasodilating drugs and some related agents. Laryngoscope 1969; 79: 1956–79
- Martinez D M. The effect of Serc (betahistine hydrochloride) on the circulation of the inner ear in experimental animals. Acta Otolaryngol (Stockh) 1972; 305: 29
- Meyer J S, Mathew N T, Hartman A, Rivera V M. Orally administered betahistine and regional cerebral blood flow in cerebrovascular disease. J Clin Pharmacol 1974; 14: 280
- Pathy J, Menon G, Reynolds A, Van Strik R. Betahistine hydrochloride (Serc) in cerebrovascular disease: A placebo-controlled study. Age Ageing 1977; 6: 179–84
- Serafin M, Khateb A, Vibert N, Violal P P, Mühlethaler M. Medial vestibular nucleus in the guinea-pig: Histaminergic receptors I. An in vitro study. Exp Brain Res 1993; 93: 242–8
- Yabe T, de Waele C, Serafin M, et al. Medial vestibular nucleus in the guinea-pig: Histaminergic receptors II. An in vivo study. Exp Brain Res 1993; 93: 249–58
- Oosterveld W J. Betahistine hydrochloride in the treatment of vertigo of peripheral vestibular origin. A double-blind placebo-controlled study. J Laryngol Otol 1984; 98: 37–41
- Laurikainen E A, Miller J M, Quirk W S, et al. Be-tahistine-induced vascular effects in the rat cochlea. Am J Otol 1993; 14: 24–30